The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Ask Questions (ASQ):Implementation of a Communication Intervention
Official Title: Ask Questions (ASQ): Implementation of a Communication Intervention to Improve Patient-Oncologist Communication in the Outpatient Medical Oncology Setting
Study ID: NCT05025748
Brief Summary: This clinical trial implements a communication intervention to improve patient-oncologist communication in the outpatient medical oncology setting. A communication brochure called the ASQ brochure may help patients prepare for the doctor visit by thinking through the questions that patients and patients' family want to ask the doctor.
Detailed Description: Patient-centered communication is critical to providing high-quality care. In patient-provider clinical interactions, providers are responsible for several aspects of patient-centered communication. However, to reach the goal of providing the best possible treatments, patients should also actively participate by asking questions and expressing their concerns. Question prompt lists, simple lists of questions provided to patients before clinic visits to help them prepare for the appointment, have been tested in several medical contexts and patient populations, including among an underserved, minority population in Detroit, and have been shown to contribute to improved outcomes related to better communication quality. Using a RE-AIM framework, this descriptive, mixed methods, single-arm intervention study assesses the implementation of an evidence-based communication intervention (question prompt list), the "ASQ brochure". The ASQ brochure is designed to improve patient-oncologist communication and other outcomes by improving patient self-efficacy for managing patient-physician interactions. Investigators will recruit 225 patients and implement the ASQ brochure at seven Karmanos Cancer Center network sites. Participants are newly diagnosed patients with (Stages I-IV) cancer for which systemic therapy is likely a recommended treatment.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Karmanos Cancer Institute at McLaren Bay Region, Bay City, Michigan, United States
Karmanos Cancer Institute at McLaren Clarkston, Clarkston, Michigan, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Karmanos Cancer Institute at McLaren Flint, Flint, Michigan, United States
Karmanos Cancer Institute at McLaren Macomb, Mount Clemens, Michigan, United States
Karmanos Cancer Institute at McLaren Central Michigan, Mount Pleasant, Michigan, United States
Karmanos Cancer Institute at McLaren Northern Michigan, Petoskey, Michigan, United States
Karmanos Cancer Institute at McLaren Port Huron, Port Huron, Michigan, United States
Name: Susan Eggly, PhD
Affiliation: Wayne State University
Role: PRINCIPAL_INVESTIGATOR